Meriam Kabbaj
Directeur Technique/Scientifique/R&D chez GENFIT
Postes actifs de Meriam Kabbaj
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENFIT | Directeur Technique/Scientifique/R&D | 01/12/2022 | - |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Directeur/Membre du Conseil | 01/01/2015 | - |
| Directeur des opérations | 01/01/2015 | - | |
| Fondateur | 01/01/2015 | - |
Historique de carrière de Meriam Kabbaj
Formation de Meriam Kabbaj
| University of Montréal | Doctorate Degree |
Statistiques
Internationale
| Canada | 2 |
| France | 2 |
| Suisse | 2 |
Opérationnelle
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENFIT | Health Technology |
| Entreprise privées | 1 |
|---|---|
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Bourse
- Insiders
- Meriam Kabbaj
- Expérience